ARCT Q1 2019 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+83.8% YoY

Gross Profit

-$3M-68.4% margin

Operating Income

-$7M-149.6% margin

Net Income

-$7M-158.3% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

-42.6%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$399,000

Balance Sheet

Total Assets

$44M

Total Liabilities

$38M

Stockholders' Equity

$6M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+83.8%
Gross Profit	-$3M	-$2M	-88.9%
Operating Income	-$7M	-$7M	+2.5%
Net Income	-$7M	-$7M	-4.8%